HomeNewsWorldChina allows COVID cases with no or mild symptoms to quarantine at home

China allows COVID cases with no or mild symptoms to quarantine at home

Most of the cases are asymptomatic infections and mild cases, with no special treatment required, the National Health Commission said in a statement.

December 07, 2022 / 11:30 IST
Story continues below Advertisement
China COVID-19
China COVID-19

China's national health authority said on Wednesday that asymptomatic COVID-19 cases and those with mild symptoms can self-treat while in quarantine at home, the strongest sign so far that China is preparing its people to live with the disease.

Most of the cases are asymptomatic infections and mild cases, with no special treatment required, the National Health Commission said in a statement.

Story continues below Advertisement

"Asymptomatic persons and mild cases can be isolated at home while strengthening health monitoring, and they can transfer to designated hospitals for treatment in a timely manner if their condition worsens," the NHC said.

For nearly three years, China has managed COVID-19 as a dangerous disease on par with bubonic plague and cholera, but since last week, top officials have acknowledged the reduced ability of the new coronavirus to cause disease while Chinese experts suggested it is not more deadly than seasonal influenza.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show
Reuters
first published: Dec 7, 2022 11:32 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!